The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

FENC FINANCIAL STATEMENTS

Fennec Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

FENCFennec Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-25 M025 M50 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue59.2 M $Gross Profit55.5 M $ · 94%Operating Income-1.2 M $ · -2%Pre-tax Income-3.1 M $ · -5%Net Income to Owners-3.3 M $ · -5%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue59.2 M $+77.8%
Gross Profit55.5 M $+85.4%
Operating Income-1.2 M $—
EBITDA-2.4 M $—
Net Income to Owners-3.3 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
025 M50 M75 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets75.8 M
  • Equity42.4 M $56%
  • Current Liabilities12.4 M $16%
  • Long-term Liabilities20.9 M $28%

Key Figures

YoY change
Total Assets75.8 M $+68.8%
Total Liabilities33.3 M $-36.4%
Total Equity42.4 M $—
Cash & ST Investments41.2 M $+120.5%
Total Debt——
Net Debt-41.2 M $-6,359.3%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-20 M020 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
010 M20 M-2 M $Operating24.6 M $Financing22.5 M $Net Change

Key Figures

YoY change
Operating Cash Flow-2 M $—
Capital Expenditures1 $-70.3%
Free Cash Flow-2 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on FENC

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.